Skip to Main Content

Paper Details

New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
Gastroenterology
36
2019
-, ATP, HCC26, Liver Cancer, Liver Cancer Cells, Oligomycin, PDX, RNA, SALL4, SALL4-knockdown cells, SALL4hi, SALL4hi cells, SALL4hi hepatocellular carcinoma and non-small-cell lung cancer cell lines, SALL4lo, SALL4lo PDX cells, SALL4lo cells, SALL4lo patient, SNU-387, SNU-387 cell lines, SNU-398, SNU-398 or HCC26, Xenograft tumors, adenosine triphosphate, adenosine triphosphate (ATP) synthase, antimycin, cancer, cancer cells, cells, efrapeptin, genes, hepatocellular carcinoma and non-small-cell lung cancer, leucinostatin, liver cancer, liver cancer cells, liver tumors, mice, mitochondrial genes, oligomycin, oncogenes, oxidative phosphorylation genes, oxygen, patient, solid tumor, solid tumor and leukemia cells, sorafenib, transcription factor SALL4, tumor, tumors, xenograft tumors
Author NameAffiliation
Mahmoud A BassalCancer Science Institute of Singapore, National University of Singapore, Singapore Harvard Stem Cell Institute, Harvard Medical School
Mahmoud A BassalCancer Science Institute of Singapore, National University of Singapore, Singapore Harvard Stem Cell Institute, Harvard Medical School
Huck-Hui NgGenome Institute of Singapore
Daniel G TenenCancer Science Institute of Singapore, National University of Singapore, Singapore Harvard Stem Cell Institute, Harvard Medical School
Daniel G TenenCancer Science Institute of Singapore, National University of Singapore, Singapore Harvard Stem Cell Institute, Harvard Medical School
  • 1 - 5

Datasets

Release 1.2